Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study

Diffuse large B-cell lymphoma can be classified by gene expression profiling into germinal center and activated B-cell subtypes with different prognoses after rituximab-CHOP. The importance of previously recognized prognostic markers, such as Bcl-2 protein expression and BCL2 gene abnormalities, has...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Visco, Carlo, Tzankov, Alexander, Xu-Monette, Zijun Y., Miranda, Roberto N., Tai, Yu Chuan, Li, Yan, Liu, Wei-min, d'Amore, Emanuele S. G., Li, Yong, Montes-Moreno, Santiago, Dybkær, Karen, Chiu, April, Orazi, Attilio, Zu, Youli, Bhagat, Govind, Wang, Huan-You, Dunphy, Cherie H., His, Eric D., Zhao, X. Frank, Choi, William WL., Zhao, Xiaoying, van Krieken, J. Han, Huang, Qin, Ai, Weiyun, O'Neill, Stacey, Ponzoni, Maurilio, Ferreri, Andres JM., Kahl, Brad S., Winter, Jane N., Go, Ronald S., Dirnhofer, Stephan, Piris, Miguel A., Møller, Michael B., Wu, Lin, Medeiros, L. Jeffrey, Young, Ken H.
Format: Artigo
Idioma:Inglês
Publicat: Ferrata Storti Foundation 2013
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3561433/
https://ncbi.nlm.nih.gov/pubmed/22929980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2012.066209
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars